These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11457994)
21. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Hiramatsu K; Tadano M; Men R; Lai CJ Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504 [TBL] [Abstract][Full Text] [Related]
22. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus]. Lin Y; Wen K; Guo Y; Qiu L; Pan Y; Yu L; Di B; Chen Y Bing Du Xue Bao; 2015 Nov; 31(6):665-73. PubMed ID: 26951013 [TBL] [Abstract][Full Text] [Related]
23. Identification of B cell epitopes of dengue virus 2 NS3 protein by monoclonal antibody. Tian Y; Chen W; Yang Y; Xu X; Zhang J; Wang J; Xiao L; Chen Z Appl Microbiol Biotechnol; 2013 Feb; 97(4):1553-60. PubMed ID: 23081772 [TBL] [Abstract][Full Text] [Related]
24. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. Goncalvez AP; Purcell RH; Lai CJ J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644 [TBL] [Abstract][Full Text] [Related]
25. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719. Ni Y; Tominaga Y; Honda Y; Morimoto K; Sakamoto S; Kawai A Microbiol Immunol; 1995; 39(9):693-702. PubMed ID: 8577283 [TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines. Falconar AK Clin Vaccine Immunol; 2008 Mar; 15(3):549-61. PubMed ID: 18160621 [TBL] [Abstract][Full Text] [Related]
27. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection. Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366 [TBL] [Abstract][Full Text] [Related]
28. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1). Gelanew T; Hunsperger E Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531 [TBL] [Abstract][Full Text] [Related]
29. Characterization and epitope mapping of Dengue virus type 1 specific monoclonal antibodies. Chen WH; Chou FP; Wang YK; Huang SC; Cheng CH; Wu TK Virol J; 2017 Oct; 14(1):189. PubMed ID: 28969658 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. Cockburn JJ; Navarro Sanchez ME; Fretes N; Urvoas A; Staropoli I; Kikuti CM; Coffey LL; Arenzana Seisdedos F; Bedouelle H; Rey FA Structure; 2012 Feb; 20(2):303-14. PubMed ID: 22285214 [TBL] [Abstract][Full Text] [Related]
31. Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies. Serafin IL; Aaskov JG Arch Virol; 2001 Dec; 146(12):2469-79. PubMed ID: 11811694 [TBL] [Abstract][Full Text] [Related]
35. A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein. Chan AH; Tan HC; Chow AY; Lim AP; Lok SM; Moreland NJ; Vasudevan SG; MacAry PA; Ooi EE; Hanson BJ PLoS One; 2012; 7(4):e33451. PubMed ID: 22509258 [TBL] [Abstract][Full Text] [Related]
36. The Neutralizing Linear Epitope of Human Herpesvirus 6A Glycoprotein B Does Not Affect Virus Infectivity. Wakata A; Kanemoto S; Tang H; Kawabata A; Nishimura M; Jasirwan C; Mahmoud NF; Mori Y J Virol; 2018 Mar; 92(5):. PubMed ID: 29212944 [TBL] [Abstract][Full Text] [Related]
37. Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Lin B; Parrish CR; Murray JM; Wright PJ Virology; 1994 Aug; 202(2):885-90. PubMed ID: 7518164 [TBL] [Abstract][Full Text] [Related]
38. Neutralizing peptide ligands selected from phage-displayed libraries mimic the conformational epitope on domain III of the Japanese encephalitis virus envelope protein. Wu SC; Lin CW Virus Res; 2001 Jul; 76(1):59-69. PubMed ID: 11376846 [TBL] [Abstract][Full Text] [Related]
39. Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing. Dowd KA; DeMaso CR; Pierson TC mBio; 2015 Nov; 6(6):e01559-15. PubMed ID: 26530385 [TBL] [Abstract][Full Text] [Related]
40. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein. Budigi Y; Ong EZ; Robinson LN; Ong LC; Rowley KJ; Winnett A; Tan HC; Hobbie S; Shriver Z; Babcock GJ; Alonso S; Ooi EE PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006209. PubMed ID: 29425203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]